Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized Multicenter Trial of Adjunctive Intravenous Therapy With Sodium-selenite(Selenase®, Double-blinded) and a Procalcitonin Guided Causal Therapy (Open) of Severe Sepsis or Septic Shock.

NCT00832039 is registered in ClinicalTrials.gov with Kompetenznetz Sepsis as lead sponsor.

NCT NCT00832039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00832039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized Multicenter Trial of Adjunctive Intravenous Therapy With Sodium-selenite(Selenase®, Double-blinded) and a Procalcitonin Guided Causal Therapy (Open) of Severe Sepsis or Septic Shock.
Lead sponsor
Kompetenznetz Sepsis
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2009
Completion date
June 30, 2013
Enrollment
1,089 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock, severe sepsis